IN VITRO ANTIPLATELET ACTIVITY OF AN ISOFLAVANONE ISOLATED FROM METHANOLIC EXTRACT OF EMBLICA OFFICINALIS FRUITS

ANILA L.; M. S. HASHIM

doi:10.22159/ijpps.2022v14i11.46212

Authors

ANILA L. Department of Biochemistry, NSS College, Nilamel, Kollam, Kerala, India 691535 https://orcid.org/0000-0001-8781-4581
M. S. HASHIM Hashim's Institute of Life Science (HILS), Karyavattom, Thiruvananthapuram, Kerala, India 695581

DOI:

https://doi.org/10.22159/ijpps.2022v14i11.46212

Keywords:

Polyphenolic compound, Emblica officinalis, In vitro platelet aggregation, Quercetin, Isoflavanone

Abstract

Objective: In this study, we aimed to isolate a polyphenolic compound from a polyphenolic-rich fraction from Emblica officinalis fruits and also study its effect on adenosine diphosphate (ADP) and collagen-induced in vitro platelet aggregation.

Methods: The polyphenolic-rich fraction was prepared by 80% methanolic extraction. The residue was extracted successively with hexane, benzene, ethyl acetate and n-butanol. Ethyl acetate residue was selected for column chromatography because of its high polyphenolic content. It was subjected to repeated column chromatography of series with different eluents of increasing polarity. A brown amorphous powder was obtained from ethyl acetate: methanol (7:3) fraction. This sample was subjected to UV-visible spectrum, IR spectrum, ¹H NMR, ¹³C NMR and electrospray mass spectrum (ES-MS) studies for its structural elucidation.

Results: A compound, 5, 7, 4'-trihydroxy 3'-methoxy isoflavanone was identified from polyphenolic rich ethyl acetate: methanol (7:3) fraction separated from the 80% methanolic extract of Embica officinalis fruits by repeated column chromatography. Yield of the compound was 421.05 mg/kg. This compound exhibited antiplatelet activity well comparable with that of quercetin.

Conclusion: The present study proved that the isolated compound 5, 7, 4'-trihydroxy 3'-methoxy isoflavanone exerts a significant inhibitory activity on ADP and collagen-induced in vitro platelet aggregation, which can be considered as an effective remedy for alleviating complications of cardiovascular diseases.

Downloads

Download data is not yet available.

References

Tapiero H, Tew KD, Ba GN, Mathe G. Polyphenols: do they play a role in the prevention of human pathologies? Biomed Pharmacother. 2002;56(4):200-7. doi: 10.1016/s0753-3322(02)00178-6, PMID 12109813.

Bloor SJ. Overview of methods for analysis and identification of flavonoids. Methods Enzymol. 2001;335:3-14. doi: 10.1016/s0076-6879(01)35227-8, PMID 11400379.

Es-Safi NE, Ghidouche S, Ducrot PH. Flavonoids: hemisynthesis, reactivity, characterization and free radical scavenging activity. Molecules. 2007;12(9):2228-58. doi: 10.3390/12092228, PMID 17962740.

Rahman MM, Rahaman MS, Islam MR, Rahman F, Mithi FM, Alqahtani T. Role of phenolic compounds in human disease: current knowledge and future prospects. Molecules. 2021;27(1):233. doi: 10.3390/molecules27010233, PMID 35011465.

Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front Physiol. 2020;11:694. doi: 10.3389/fphys.2020.00694, PMID 32714204.

Dubois Deruy E, Peugnet V, Turkieh A, Pinet F. Oxidative stress in cardiovascular diseases. Antioxidants (Basel). 2020;9(9): 864. doi: 10.3390/antiox9090864, PMID 32937950.

Sharifi Rad J, Quispe C, Zam W, Kumar M, Cardoso SM, Pereira OR. Phenolic bioactives as antiplatelet aggregation factors: the pivotal ingredients in maintaining cardiovascular health. Oxid Med Cell Longev. 2021;2021:2195902. doi: 10.1155/ 2021/2195902, PMID 34447485.

Hasan MR, Islam MN, Islam MR. Phytochemistry, pharmacological activities and traditional uses of Emblica officinalis: a review. Int Curr Pharm J. 2016;5(2):14-21. doi: 10.3329/icpj.v5i2.26441.

Raghavendra RH, Naidu KA. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Prostaglandins Leukot Essent Fatty Acids. 2009;81(1):73-8. doi: 10.1016/j.plefa.2009.04.009, PMID 19501497.

Meshkini A, Tahmasbi M. Antiplatelet aggregation activity of walnut hull extract via suppression of reactive oxygen species generation and caspase activation. J Acupunct Meridian Stud. 2017;10(3):193-203. doi: 10.1016/j.jams.2017.02.007, PMID 28712479.

Mann P, Tofern B, Kaloga M, Eich E. Flavonoid sulfates from the convolvulaceae1Part 7 in the series “Phytochemistry and Chemotaxonomy of the Convolvulaceae”. Phytochemistry. 1999;50(2):267-71. doi: 10.1016/S0031-9422(98)00502-0.

Anila L. Antioxidant action of flavonoids from Mangifera indica and Emblica officinalis in hypercholesterolemic rats. Food Chem. 2003;83(4):569-74. doi: 10.1016/S0308-8146(03)00155-9.

Zaragoza C, Monserrat J, Mantecon C, Villaescusa L, Alvarez Mon MA, Zaragoza F. Binding and antiplatelet activity of quercetin, rutin, diosmetin, and diosmin flavonoids. Biomed Pharmacother. 2021;141:111867. doi: 10.1016/j.biopha. 2021.111867, PMID 34229245.

Roest M, Sixma JJ, Wu YP, Ijsseldijk MJW, Tempelman M, Slootweg PJ. Platelet adhesion to collagen in healthy volunteers is influenced by variation of both α2β1 density and von willebrand factor. Blood J Am Soc Hematol. 2000;96(4):1433-7.

Markham KR. Techniques of flavonoid identification. Academic press; 1982.

Lanza F, Beretz A, Stierle A, Hanau D, Kubina M, Cazenave JP. Epinephrine potentiates human platelet activation but is not an aggregating agent. American Journal of Physiology-Heart and Circulatory Physiology. 1988;255(6):H1276-88. doi: 10.1152/ajpheart.1988.255.6.H1276.

Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen‐stimulated platelet activation pathway in humans. J Thromb Haemost. 2004;2(12):2138-45. doi: 10.1111/j.1538-7836.2004.01067.x, PMID 15613018.

Russo P, Tedesco I, Russo M, Russo GL, Venezia A, Cicala C. Effects of de-alcoholated red wine and its Phenolic fractions on platelet aggregation. Nutr Metab Cardiovasc Dis. 2001;11(1):25-9. PMID 11383321.

Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr. 1998;67(2):255-62. doi: 10.1093/ajcn/67.2.255, PMID 9459373.

Bojic M, Debeljak Z, Medic Saric M, Tomicic M. Interference of selected flavonoid aglycons in platelet aggregation assays. Clin Chem Lab Med. 2012;50(8):1403-8. doi: 10.1515/cclm-2011-0960, PMID 22868805.

Gaspar RS, da Silva SA, Stapleton J, Fontelles JLL, Sousa HR, Chagas VT. Myricetin, the main flavonoid in syzygium cumini leaf, is a novel inhibitor of platelet thiol isomerases PDI and ERp5. Front Pharmacol. 2019;10:1678. doi: 10.3389/fphar.2019.01678, PMID 32116678.

Freedman JE, Loscalzo J. Platelet–monocyte aggregates: bridging thrombosis and inflammation. Circulation. 2002;105(18):2130-2. doi: 10.1161/01.cir.0000017140.26466.f5, PMID 11994242.

Olas B. A review of in vitro studies of the anti-platelet potential of citrus fruit flavonoids. Food Chem Toxicol. 2021;150:112090. doi: 10.1016/j.fct.2021.112090, PMID 33636212.

Zhang YX, Yang TT, Xia L, Zhang WF, Wang JF, Wu YP. Inhibitory effect of propolis on platelet aggregation in vitro. J Healthc Eng. 2017;2017:3050895. doi: 10.1155/2017/3050895, PMID 29129989.

Sharifi Rad J, Quispe C, Shaheen S, El Haouari M, Azzini E, Butnariu M. Flavonoids as potential anti-platelet aggregation agents: from biochemistry to health-promoting abilities. Crit Rev Food Sci Nutr. 2021:1-14. doi: 10.1080/ 10408398.2021.1924612.

Freynhofer KM, Bruno V, Wojta J, Huber K. The role of platelets in athero-thrombotic events. Curr Pharm Des. 2012;18(33):5197–214.